Lataa...

Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity

BACKGROUND: Premature neonates are at risk for severe anemia and erythropoietin is the most important hormone in erythropoiesis. The aim of this study was to evaluate the influence of oral recombinant human erythropoietin (rhEPO) in proving erythropoiesis in neonates. METHODS: This was a randomized...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Saeidi, R, Banihashem, A, Hammoud, M, Gholami, M
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Kowsar 2012
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3372031/
https://ncbi.nlm.nih.gov/pubmed/22737576
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!